Gerresheimer (ETR:GXI) has been given a €81.00 ($94.19) target price by research analysts at Berenberg Bank in a research note issued on Thursday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 9.98% from the stock’s previous close.
Other analysts have also issued research reports about the company. DZ Bank lowered NVIDIA to a “sell” rating and set a $170.00 price objective on the stock. in a research note on Friday, April 12th. Deutsche Bank dropped their price objective on from GBX 217 ($2.84) to GBX 175 ($2.29) and set a “sell” rating on the stock in a research note on Monday, June 24th. Independent Research set a €72.00 ($83.72) price objective on Gerresheimer and gave the company a “neutral” rating in a research note on Friday, April 12th. Hauck & Aufhaeuser set a €120.00 ($139.53) price objective on Hypoport and gave the company a “sell” rating in a research note on Thursday, April 11th. Finally, Kepler Capital Markets set a €19.00 ($22.09) price objective on Rhoen Klinikum and gave the company a “sell” rating in a research note on Thursday, April 11th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of €69.17 ($80.43).
GXI opened at €73.65 ($85.64) on Thursday. Gerresheimer has a 52-week low of €51.10 ($59.42) and a 52-week high of €80.25 ($93.31). The company has a market capitalization of $2.31 billion and a price-to-earnings ratio of 12.90. The company has a quick ratio of 0.51, a current ratio of 0.78 and a debt-to-equity ratio of 68.19. The stock’s 50-day moving average is €65.08.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Read More: Trading Ex-Dividend Strategy
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.